CTRI/2017/07/008995已完成3 期
â??Clinical Profile of Hepatic Encephalopathy and comparison of Polyethylene Glycol (PEG) and Lactulose in the treatment of Overt Hepatic Encephalopathyâ?? - HELP-II
Institute of Medical Sciences0 个研究点目标入组 57 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 57
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. All patients diagnosed with Hepatic Encephalopathy presenting to the inpatient care at the department of Gastroenterology, IMS, BHU
- •2. Age 18 to 80 years
- •3. Diagnosis of Chronic Liver Disease from any cause
- •4. The availability of a Legally Authorized Representative for interview and consent
排除标准
- •1.Patients with Hepatic Encephalopathy
- •Grade I and Grade IV.
- •2.Acute Liver failure
- •3.More than 1 dose of lactulose before
- •4.No Legally Authorized Representative to
- •give consent/ Refusal of consent
- •5.Previously recruited in the present
- •6.Serum Creatinine more than 2.5 mg /dl
- •7.Treated with Vasopressors
- •8.Pregnancy
研究者
相似试验
已完成
不适用
Examination of covert hepatic encephalopathyiver cirrhosisJPRN-UMIN000037003ara Medical University311
Unknown
2 期
Nitazoxanide Plus Lactulose Versus Lactulose Alone Treatment of Hepatic EncephalopathyEncephalopathy, HepaticNCT02464124Sherief Abd-Elsalam120
招募中
不适用
Psychometric hepatic encephalopathy score for diagnosis of minimal hepatic encephalopathy in Thai cirrhotic patients.Minimal hepatic encephalopathyMinimal hepatic encephalopathy, cirrhosis, psychometric hepatic encephalopathy score, Thai normsTCTR20221014005/A190
尚未招募
不适用
Clinical and radiological features of encephalopathy caused by shiga toxin producing enterohemorrhagic Escherichia coli, case series studyJPRN-UMIN000037166ational Center for Child Health and Development50
进行中（未招募）
4 期
Minimal hepatic encephalopathy (MHE) – influence of therapy with rifaximin on MHE and on the intestinal microbiome in patients with liver cirrhosis – the RiMINI-TrialK72.7DRKS00006359Medizinische Fakultät der Otto-von-Guericke Universität5